An Olympus Corp subsidiary pleaded guilty on Monday and agreed to pay $85 million to resolve charges that it failed to file reports with U.S. regulators regarding infections connected to its duodenoscopes while continuing to sell the medical devices used to view the gastrointestinal tract.

from Reuters: Health News https://ift.tt/2B6tEwg
via IFTTT
from Reuters: Health News https://ift.tt/2B6tEwg
via IFTTT
Post a Comment